| Clinical data | |
|---|---|
| Other names | RS-40584; 6α,9α-Difluoro-11β,16α,17α-trihydroxy-3,20-dioxopregna-1,4-dien-21-al 21-(dimethyl acetal) cyclic 16,17-acetal with acetone; 6α,9α-Difluoro-11β-hydroxy-21,21-dimethoxy-16α,17α-((1-methylethylidene)- bis(oxy))pregna-1,4-diene-3,20-dione |
| Drug class | Corticosteroid;Glucocorticoid |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.056.413 |
| Chemical and physical data | |
| Formula | C26H34F2O7 |
| Molar mass | 496.548 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Flumoxonide (developmental code nameRS-40584) is asyntheticglucocorticoidcorticosteroid which was never marketed.[1]